Publikasi Scopus 2024 per tanggal 30 September 2024 (820 artikel)

Introduction: Although studies have indicated comparable outcomes between RFA and surgical resection in early HCC, there is still unclear evidence of benefit in larger tumor sizes. This study aimed to assess the efficacy and safety of RFA versus surgical resection in HCC patients, considering nodule size with a cutoff at 3 cm. Methods: A comprehensive search of multiple databases was conducted. The systematic review and meta-analysis followed the PRISMA guidelines. Result: Surgical resection showed superior OS (HR = 1.18, 95% CI: 1.11–1.27, p = 0.008) and RFS (HR = 1.17, 95% CI: 1.11–1.25, p < 0.00001), compared to RFA. For nodules less than 3 cm or larger than 5 cm, the OS and RFS in the surgical resection group were significantly higher than those in the RFA group, while no significant differences were observed for nodules sized 3–5 cm. However, significantly more adverse events occurred following surgical resection (OR = 0.43, 95% CI: 0.33–0.56, P < 0.00001). Conclusion: Surgical resection has better OS and RFS compared to RFA for liver tumors less than 3 cm or larger than 5 cm. For liver tumors sized 3–5 cm, RFA and surgical resection yield similar findings. RFA may become a preferable option in these 3–5 cm tumors due to its comparable efficacy and fewer adverse events for patients unsuitable for surgery. © 2024